$227.17
2.77% yesterday
NYSE, Dec 12, 10:13 pm CET
ISIN
US0758871091
Symbol
BDX

Becton, Dickinson & Stock price

$227.17
-4.10 1.77% 1M
-6.82 2.91% 6M
-16.66 6.83% YTD
-9.50 4.01% 1Y
-19.30 7.83% 3Y
-31.62 12.22% 5Y
+93.61 70.09% 10Y
NYSE, Closing price Thu, Dec 12 2024
+6.13 2.77%
ISIN
US0758871091
Symbol
BDX
Sector

Key metrics

Market capitalization $65.68b
Enterprise Value $84.30b
P/E (TTM) P/E ratio 38.24
EV/FCF (TTM) EV/FCF 27.43
EV/Sales (TTM) EV/Sales 4.18
P/S ratio (TTM) P/S ratio 3.26
P/B ratio (TTM) P/B ratio 2.54
Dividend yield 1.67%
Last dividend (FY24) $3.80
Revenue growth (TTM) Revenue growth 4.16%
Revenue (TTM) Revenue $20.18b
EBIT (operating result TTM) EBIT $2.88b
Free Cash Flow (TTM) Free Cash Flow $3.07b
Cash position $2.30b
EPS (TTM) EPS $5.94
P/E forward 25.83
P/S forward 2.98
EV/Sales forward 3.83
Short interest 0.73%
Show more

Is Becton, Dickinson & a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,889 stocks worldwide.

Becton, Dickinson & Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Becton, Dickinson & forecast:

16x Buy
89%
2x Hold
11%

Analyst Opinions

18 Analysts have issued a Becton, Dickinson & forecast:

Buy
89%
Hold
11%

Financial data from Becton, Dickinson &

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
20,178 20,178
4% 4%
100%
- Direct Costs 11,025 11,025
2% 2%
55%
9,153 9,153
12% 12%
45%
- Selling and Administrative Expenses 2,936 2,936
25% 25%
15%
- Research and Development Expense 1,190 1,190
4% 4%
6%
5,027 5,027
10% 10%
25%
- Depreciation and Amortization 2,144 2,144
1% 1%
11%
EBIT (Operating Income) EBIT 2,883 2,883
19% 19%
14%
Net Profit 1,726 1,726
16% 16%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Becton, Dickinson & directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Becton, Dickinson & Stock News

Positive
Seeking Alpha
about 20 hours ago
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance Health, Becton, Dickinson, LyondellBasell, Rogers Communications and Rexford Industrial Realty. These companies offer a 3.7% yield and a 27% discount to fair value, and they have historically outperf...
Positive
Seeking Alpha
6 days ago
The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Dividend Aristocrats offer a better alternative to the traditional 60-40 portfolio and S&P. These 12 Aristocrats provide a 3.2% yield, 14% discount, 22% upside potential next year, and 10% long-term inc...
Neutral
Investopedia
7 days ago
With a new presidential administration set to take office on Jan. 20, 2025, some investors may be uncertain about how new policies and personnel will affect the stock market and interest rates. Will tariffs, discarded trade deals, and frayed alliances help or hurt the market?
More Becton, Dickinson & News

Company Profile

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

Head office United States
CEO Thomas Polen
Employees 74,000
Founded 1897
Website www.bd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today